Severe hyponatremia by oxcarbazepine in an elderly;Hiponatremia grave por oxcarbacepina en un anciano

Revista de Neurologia

Volumn 48, Issue 11, 2009, Pages 614-615

  Valentini, S ^a   Arbaizar Rodriguez P ^b,c   Abarca Costalago, M ^b,c   Valdivielso Felices, Pedro ^b,c   Gonzalez Santos P ^b,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; ENALAPRIL; FORMOTEROL; OMEPRAZOLE; OXCARBAZEPINE; SULPIRIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DRUG DERIVATIVE;

AGED; CASE REPORT; ELDERLY CARE; HUMAN; HYPONATREMIA; LETTER; MALE; CHEMICALLY INDUCED DISORDER; EPILEPSY;

AGED; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; HUMANS; HYPONATREMIA; MALE;

EID: 68849100231     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4811.2008717     Document Type: Letter

References (11)

1. Velez L, Selwa LM. Seizure disorders in the elderly. Am Fam Physician 2003; 67: 325-332
2. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004; 3: 618-621 (Pubitemid 39221928)
3. Rufo-Campos M, Carreño-Martínez M. Estudio observacional de los patrones de utilización de carbamacepina y oxcarbacepina en pacientes adultos con epilepsia parcial en España. Rev Neurol 2007; 45: 257-263 (Pubitemid 350292945)
4. Ruiz-Miyares F, Deleu D, D'Souza A, Akhtar N, Al-Hail H, Mesraoua B. Hiponatremia, mielinólisis pontina y rabdomiólisis. Rev Neurol 2008; 46: 574-575
5. Horga de la Parte JF, Horga A. Oxcarbacepina en el tratamiento de la epilepsia. Revisión y actualización. Rev Neurol 2006; 42: 95-113.
6. Kutluay E, McCague K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003; 4: 175-180 (Pubitemid 37184590)
7. Dogan EA, Usta BE, Bilgen R, Senol Y, Aktekin B. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. Epilepsy Behav 2008; 13: 156-161
8. Schmidt D, Arroyo S, Baulac M, Dam M, Dulac O, Friis ML, et al. Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view. Acta Neurol Scand 2001; 104: 167-170 (Pubitemid 32831779)
9. Sachdeo RC, Wasserstein A, Mesenbrink PJ, D'Souza J. Effects of oxcarbazepine on sodium concentration and water handling. Ann Neurol 2002; 51: 613-620 (Pubitemid 34438701)
10. Mavragani CP, Vlachoyiannopoulos PG. Is polydipsia sometimes the cause of oxcarbazepine-induced hyponatremia? Eur J Intern Med 2005; 16: 296-297
11. Chan TY. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs Aging 1997; 11: 27-44.